Concepedia

Publication | Open Access

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

683

Citations

31

References

2008

Year

Abstract

Weekly paclitaxel at the dose schedule used in the current study was well tolerated and demonstrated clinical benefit.

References

YearCitations

Page 1